Ehlers-Danlos syndrome refers to a spectrum of connective tissue disorders typically caused by mutations in genes responsible for the synthesis of collagen. Patients with Ehlers-Danlos syndrome often exhibit hyperflexibility of joints, increased skin elasticity, and tissue fragility. Vascular Ehlers-Danlos (vEDS) is a subtype of Ehlers-Danlos syndrome with a predilection to involve blood vessels. As such, it often manifests as vascular aneurysms and vessel rupture leading to hemorrhage. There are few reports describing primary prevention of aneurysms in the setting of undiagnosed, suspected vEDS. We present a case of a 30-year-old woman who presents with a pulsatile neck mass found to have multiple arterial aneurysms on imaging, hyperflexibility, and characteristic facial features consistent with vEDS. As described in this case, management of a suspected connective tissue disorder is a multidisciplinary approach including vascular surgery, medical therapy, and genetic testing to confirm the diagnosis. We review literature regarding the care of patients with vascular Ehlers-Danlos as it might pertain to hospitalized patients.
vascular Ehlers-danlos aneurysm
This is a preview of subscription content, log in to check access.
Compliance with Ethical Standards
Conflict of interest
The authors declare that they do not have a conflict of interest.
Barabas AP. Heterogeneity of the Ehlers-Danlos syndrome. Description of clinical types and a hypothesis to explain the basic defect. BMJ 1967;2:612–3.CrossRefGoogle Scholar
Barabas AP. Vascular complications in the Ehlers-Danlos syndrome, with especial reference to the “arterial type” or Sack’s syndrome. J Cardiovasc Surg 1972;13:160.Google Scholar
Pope FM, Martin GR, Lichtenstein JR, et al. Patients with Ehlers-Danlos syndrome type IV lack type III collagen. Proc Natl Acad Sci 1975;72(4):1314–6.CrossRefGoogle Scholar
Oderich GS, Panneton JM, Bower TC, et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg. 2005;42(1):98–106.CrossRefGoogle Scholar
Kamiya K, Yoshizu A, Kashizaki F. Vascular-type Ehlers-Danlos syndrome incidentally diagnosed at surgical treatment for hemothorax; report of a case. Kyobu Geka. 2013;66(2):173–5.PubMedGoogle Scholar
Leistritz DF, Pepin MG, Schwarze U, et al. COL3A1 haploinsufficiency results in a variety of Ehlers-Danlos syndrome type IV with delayed onset of complications and longer life expectancy. Genet Med. 2011;13(8):717–22.CrossRefGoogle Scholar
Jørgensen A, Fagerheim T, Rand-Hendriksen S, et al. Vascular Ehlers-Danlos Syndrome in siblings with biallelic COL3A1 sequence variants and marked clinical variability in the extended family. Eur J Hum Genet. 2015;23(6):796–802.CrossRefGoogle Scholar
Pepin M, Byers P. Ehlers-Danlos Syndrome, Vascular Type. Gene Reviews. Initial Posting: September 2, 1999; Last Update: May 3, 2011.Google Scholar
Malfait F, Francomano C, Byers P, et al. The 2017 international classification of the Ehlers–Danlos syndromes. Am J Med Genet Part C Semin Med Genet. 2017;175C:8–26.Google Scholar
Beighton P, De Paepe A, Steinmann B, et al. Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet 1998;77:31–7CrossRefGoogle Scholar
Frank M, Says J, Denarié N, et al. Successful segmental thermal ablation of varicose saphenous veins in a patient with confirmed vascular Ehlers-Danlos syndrome. Phlebology. 2016;31(3):222–4.CrossRefGoogle Scholar
Inokuchi R, Kurata H, Endo K, et al. Vascular Ehlers-Danlos syndrome without the characteristic facial features: a case report. Medicine (Baltimore). 2014;93(28):e291.CrossRefGoogle Scholar
Smits-Engelsman B, Klerks M, Kirby A. Beighton score: A valid measure for generalized hypermobility in children. J Pediatr. 2011;158:119–123123:e111-114.Google Scholar
Oderich GS, Panneton JM, Bower TC et al. The spectrum, management and clinical outcome of Ehlers-Danlos syndrome type IV: a 30-year experience. J Vasc Surg. 2005;42:98–106.CrossRefGoogle Scholar
Zilocchi M, Macedo T, Oderich G, et al. Vascular Ehlers-Danlos Syndrome: Imaging Findings. Am J Rad. 2007;189:712–719.Google Scholar
Bergqvist D, Björck M, Wanhainen A. Treatment of vascular Ehlers-Danlos syndrome: a systematic review. Annals of Surgery. 2013;258(2):257–261.CrossRefGoogle Scholar
Linfante I, Lin E, Knott E, et al. Endovascular repair of direct carotid-cavernous fistula in Ehlers-Danlos type IV. J Neurointerv Surg. 2015;7(1):e3.CrossRefGoogle Scholar
Iida Y, Obitsu Y, Komai H, et al. Successful coil embolization for rupture of the subclavian artery associated with Ehlers-Danlos syndrome type IV. J Vasc Surg. 2009;50(5):1191–5.CrossRefGoogle Scholar
Ong KT, Perdu J, De Backer J, et al. Effect of celiprolol on prevention of cardiovascular events in vascular Ehlers-Danlos syndrome: a prospective randomised, open, blinded-endpoints trial. Lancet. 2010;376(9751):1476–84.CrossRefGoogle Scholar
Hugon-Rodin J, Lebegue G, Becourt S, et al. Gynecologic symptoms and the influence on reproductive life in 386 women with hypermobility type ehlers-danlos syndrome: a cohort study. Orphanet J Rare Dis. 2016;11(1):124.CrossRefGoogle Scholar
Shields LBE, Rolf CM, Davis GJ, et al. Sudden and unexpected death in three cases of Ehlers-Danlos syndrome type IV. J Forensic Sciences. 2010;55(6):1641–1645.CrossRefGoogle Scholar
Callewaert B, Malfait F, Loeys B, et al. Ehlers-Danlos syndrome and Marfan syndrome; Best Practice and Research. Clinical Rheumatology. 2008;22:165–189.CrossRefGoogle Scholar
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.